PATENT CLAIM ANALYSIS

Application Number: 16036619
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "093210"]

Abstract:
The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.

Claim (Index 11):
The method of  claim 9 , wherein said wounds are selected from venous ulcers, diabetic ulcers, pressure ulcers, burns, ulcerative colitis, mucosal injuries, internal injuries, or external injuries.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.85
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13343314', '10909119', '12690160', '14335534', '11297916']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8583943307603622
- 35 USC 102 Novelty (BERT): 0.5876458466971111
- Combined Prediction Score: 0.8313194823540371
- Mean Citation Score: 616.6766919999999
- Max Citation Score: 631.53076
- Similarity Product: 402.8893038943338

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test